(164b) Digital Twins for Continuous Manufacturing in Pharma: The Case of Dissolved Oxygen Control
AIChE Annual Meeting
2024
2024 AIChE Annual Meeting
Topical Conference: Next-Gen Manufacturing
Industry 4.0, Digital Twins, and Digital Transformation
Monday, October 28, 2024 - 12:50pm to 1:10pm
An original digital twin platform is proposed for plug-and-play interaction with the existing closed loop regulation of DO in the bioreactor. It performs critical parametersâ identification and enables synthesis of advanced control strategies for improved regulation of DO concentration levels. The platform is designed to cope with real-world challenges at the manufacturing level, that include but are not limited to corrupted data, unmeasurable disturbances, insufficient knowledge of process dynamics, modelling gaps and limited space for experimental designs. The platform consists of a blend of computation and processing components, that perform sequential calculations for on-the-fly, rapid learning, and system identification. It performs joint system identification and advanced control with respect to regulation of process of interest.
Our case study considers a fictitious problem of regulation of DO concentration levels in bioprocess setup that mimics Merckâs CM production line. We demonstrate how the proposed digital twin architecture combines heterogeneous data from the established closed-loop process, informs the mass balance model that dynamic DO concentration follows. The identification part provides estimates of constant (e.g. kLa coefficients, time-delays etc.) as well as non-constant parameters, such as specific oxygen uptake rate. System identification is essentially an intermediate step of an inverse engineering task that delivers an informed digital twin model. The latter model will then be the basis to design model reference advanced controls. We show that the proposed Digitally Twin-enabled joint dynamic controller outperforms the existing PID control structures.